EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 20.60
+0.05 (0.24%)
At close: Jul 24, 2026
EQL Pharma AB Income Statement
Financials in millions SEK. Fiscal year is April - March.
Millions SEK. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 432.66 | 373.52 | 264.17 | 259.91 | 409.75 | |
Revenue Growth (YoY) | 15.83% | 41.39% | 1.64% | -36.57% | 128.73% |
Cost of Revenue | 269.82 | 217.56 | 149.12 | 144.06 | 314.02 |
Gross Profit | 162.84 | 155.95 | 115.05 | 115.85 | 95.73 |
Selling, General & Admin | 102.92 | 78.46 | 70.8 | 59.79 | 48.16 |
Research & Development | 14.33 | 11.26 | 12.09 | 15.14 | 9.13 |
Other Operating Expenses | -3.1 | -1.14 | -0.46 | -0.41 | -0.4 |
Total Operating Expenses | 114.16 | 88.58 | 82.43 | 74.51 | 56.9 |
Operating Income | 48.69 | 67.37 | 32.62 | 41.34 | 38.84 |
Interest Income | - | 0.01 | 1.72 | 0 | 0 |
Interest Expense | -30.49 | -13.02 | -5.73 | -2.37 | -2.87 |
Other Non-Operating Income (Expense) | 0.01 | - | - | - | - |
Total Non-Operating Income (Expense) | -30.48 | -13.02 | -4.01 | -2.37 | -2.87 |
Pretax Income | 18.21 | 54.35 | 28.6 | 38.97 | 35.97 |
Provision for Income Taxes | 5.67 | 11.23 | 5.9 | 8.05 | 4.42 |
Net Income | 12.54 | 43.12 | 22.71 | 30.92 | 31.55 |
Net Income to Common | 12.54 | 43.12 | 22.71 | 30.92 | 31.55 |
Net Income Growth | -70.93% | 89.93% | -26.57% | -1.99% | 204.32% |
Shares Outstanding (Basic) | 30 | 29 | 29 | 29 | 29 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 |
Shares Change (YoY) | 0.92% | 0.34% | 0.91% | -0.10% | 1.69% |
EPS (Basic) | 0.42 | 1.48 | 0.78 | 1.06 | 1.09 |
EPS (Diluted) | 0.42 | 1.44 | 0.76 | 1.04 | 1.09 |
EPS Growth | -70.83% | 89.47% | -26.92% | -4.59% | 202.78% |
Free Cash Flow | 22.92 | -30.78 | -12.36 | 27.16 | 41.2 |
Free Cash Flow Growth | - | - | - | -34.08% | -31.39% |
Free Cash Flow Per Share | 0.76 | -1.03 | -0.41 | 0.92 | 1.39 |
Gross Margin | 37.64% | 41.75% | 43.55% | 44.57% | 23.36% |
Operating Margin | 11.25% | 18.04% | 12.35% | 15.90% | 9.48% |
Profit Margin | 2.90% | 11.54% | 8.59% | 11.90% | 7.70% |
FCF Margin | 5.30% | -8.24% | -4.68% | 10.45% | 10.06% |
EBITDA | 48.69 | 67.37 | 32.62 | 41.34 | 38.84 |
EBIT | 48.69 | 67.37 | 32.62 | 41.34 | 38.84 |
EBIT Margin | 11.25% | 18.04% | 12.35% | 15.90% | 9.48% |
Effective Tax Rate | 31.13% | 20.66% | 20.62% | 20.65% | 12.28% |